Galmed Pharmaceuticals(GLMD) - 2019 Q3 - Earnings Call Transcript

Galmed Pharmaceuticals Ltd (NASDAQ:GLMD) Q3 2019 Earnings Conference Call November 6, 2019 8:30 AM ET Company Participants Allen Baharaff - Chairman, CEO & President Yohai Stenzler - CFO & Controller Liat Hayardeny - Chief Scientific Officer Tali Gorfine - Chief Medical Officer Conference Call Participants Steven Seedhouse - Raymond James & Associates Antonio Arce - H.C. Wainwright & Co. Adam Walsh - Stifel, Nicolaus & Company Paul O'Brien - Roth Capital Mayank Mamtani - B. Riley FBR, Inc. Kristen Kluska - ...